Stuttgart
10.02.26 | 13:16
0,025 Euro
-20,32 % -0,006
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,014 | 0,040 | 07:03 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Change of issuer name and symbol for Karolinska Development AB | 78 | GlobeNewswire | As from February 10, 2026, Karolinska Development AB will change issuer name and symbol.
Old issuer name: Karolinska Development AB
New issuer name: KDventures AB
Old symbol: KDEV
New symbol: KDV
ISIN... ► Artikel lesen | |
| Fr | Karolinska Development AB (publ): Karolinska Development's portfolio company SVF Vaccines and Novakand Pharma enters into a reverse acquisition agreement | 84 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, February 6, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has entered into a reverse acquisition agreement with Novakand... ► Artikel lesen | |
| 28.01. | Karolinska Development AB: Karolinska Development AB (publ) announces the outcome of the rights issue and change of the company name to KDventures AB | 230 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 23.01. | Karolinska Development AB (publ): Karolinska Development AB receives additional guarantee commitments in ongoing rights issue | 320 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 21.01. | Karolinska Development AB (publ): Karolinska Development's portfolio company Dilafor signs binding term sheet with Exeltis for a license agreement regarding tafoxiparin | 146 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN - January 21, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has signed a binding term sheet with Exeltis, a global Women's... ► Artikel lesen | |
| 13.01. | The subscription period in Karolinska Development AB (publ)'s rights issue begins today | 1 | GlobeNewswire (USA) | ||
| 12.01. | Listing of subscription rights and paid subscription shares of Karolinska Development AB | 176 | GlobeNewswire | With effect from January 13, 2026, the subscription rights of Karolinska Development AB will be traded on the list for Equity rights. Trading will continue up until and including January 22, 2026.
... ► Artikel lesen | |
| KDVENTURES Aktie jetzt für 0€ handeln | |||||
| 09.01. | Karolinska Development AB (publ) announces publication of information document in connection with upcoming rights issue | 130 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 08.01. | Karolinska Development AB (publ): Karolinska Development's Extraordinary General Meeting 2026 | 277 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN - January 8, 2026. Karolinska Development AB (publ) ("Karolinska Development" or the "Company") held an Extraordinary General Meeting on January 8, 2026, at which the shareholders... ► Artikel lesen | |
| 07.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 07.01.2026 | 551 | Xetra Newsboard | Das Instrument SFTU US83404D1090 SOFTBANK GR.UNS.ADR1/2/ON EQUITY wird cum Kapitalmassnahme gehandelt am 07.01.2026 und ex Kapitalmassnahme am 08.01.2026 The instrument SFTU US83404D1090 SOFTBANK GR.UNS.ADR1/2/ON... ► Artikel lesen | |
| 22.12.25 | Karolinska Development AB (publ): Karolinska Development's portfolio company SVF Vaccines plans for listing on Nasdaq First North Premier through reverse takeover ahead of accelerated vaccine development | 165 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, December 22, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has signed a non-binding letter of intent (LOI) with Novakand... ► Artikel lesen | |
| 11.12.25 | Karolinska Development AB (publ): Karolinska Development's portfolio company SVF Vaccines presents new preclinical data demonstrating extended effect of SVF-001 in chronic hepatitis B and D | 171 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, December 11, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has presented new preclinical data on its immunotherapy SVF-001... ► Artikel lesen | |
| 10.12.25 | Karolinska Development AB (publ): Karolinska Development's portfolio company Modus Therapeutics initiates dosing in phase 2a study in patients with chronic kidney disease with anemia | 173 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN December 10, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company, Modus Therapeutics, has dosed the first patient in the phase 2a... ► Artikel lesen | |
| 10.12.25 | Karolinska Development AB (publ): Karolinska Development's portfolio company AnaCardio presents positive top-line data from the phase 2a study of its drug candidate AC01 | 130 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN December 10, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has reported strong, positive results from the phase 2a... ► Artikel lesen | |
| 02.12.25 | Notice of Extraordinary General Meeting in Karolinska Development AB (publ) | 101 | GlobeNewswire (Europe) | The shareholders of Karolinska Development AB (publ), reg. no. 556707-5048, ("Karolinska Development" or the "Company") are invited to the Extraordinary General Meeting ("EGM"), on Thursday January... ► Artikel lesen | |
| 01.12.25 | Karolinska Development Launches Rights Issue To Fund Portfolio Growth | 2 | RTTNews | ||
| 01.12.25 | Karolinska Development AB (publ) announces a rights issue of up to approximately SEK 203 million, subject to subsequent approval by the Extraordinary General Meeting, and proposes change of company name to KDventures AB | 157 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH... ► Artikel lesen | |
| 17.11.25 | Karolinska Development AB (publ): Karolinska Development's portfolio company Umecrine Cognition publishes data on the benefits of early treatment with golexanolone in Parkinson's disease | 1 | GlobeNewswire (USA) | ||
| 14.11.25 | Karolinska Development AB (publ): Interim Report - January-September 2025 | 163 | GlobeNewswire (Europe) | STOCKHOLM - 14 November 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report January-September 2025. The full report is available on the Company's website. "We... ► Artikel lesen | |
| 04.11.25 | Karolinska Development AB (publ): Karolinska Development's portfolio company Modus Therapeutics receives approval for second part of phase 2 study in chronic kidney disease with anemia | 185 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN November 4, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company, Modus Therapeutics, has received regulatory approval to initiate... ► Artikel lesen |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NAKIKI | 0,473 | +21,91 % | Nakiki - Deutsche Strategy? Oder sogar besser? CEO Andreas Wegerich hat einiges vor. Interview | Nakiki SE - eine deutsche Strategy? Zumindest verfolgt man ein ähnliches Geschäftskonzept. Ob man aktuell vom Timing her "trifft", mag von einigen bezweifelt werden. Andererseits: Sofern Bitcoin & Co.... ► Artikel lesen | |
| AIFINYO | 2,240 | -16,42 % | DEWB: Wertberichtigungsbedarf bei aifinyo belastet Jahresergebnis | Nächste Gewinnwarnung nun auch bei der Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG (ISIN: DE000 A41YCR 9): So werde das 2025er-Jahresergebnis durch eine außerplanmäßige Abschreibung im... ► Artikel lesen | |
| ISHARES BITCOIN TRUST | 40,100 | 0,00 % | Better 52-Week-Low Buy: Bitcoin or the iShares Bitcoin Trust ETF? | ||
| ALLIANZ | 377,90 | -2,45 % | Blauer Riese toppt jedes Tagesgeld: Drei Jahre lang 7,00 Prozent Zinsen mit der Allianz verdienen | Clever & smart aufgepasst: Es gibt hohe Zinsen mit der Allianz. Allerdings sollte man schnell sein. Wie Sie sich jetzt 7,00 Prozent für ganze drei Jahre sichern - und für wen sich die Offerte lohnt.... ► Artikel lesen | |
| MUENCHENER RUECK | 527,20 | -0,53 % | Munich Re: Das macht jetzt Mut | Die Aktie des französischen Rückversicherers SCOR hat nach Vorlage frischer Zahlen um rund vier Prozent zugelegt. Die Signale aus der wichtigen Erneuerungsrunde zum 1. Januar stimmen auch für Branchenprimus... ► Artikel lesen | |
| DEUTSCHE BANK | 31,935 | +0,54 % | Deutsche Bank: Da bahnt sich was an - Anleger sollten profitieren | Europäische Bankaktien zeigen sich auch 2026 bisher stark. Nach dem überaus fulminanten letzten Jahr zogen die Kurse auch im Januar weiter an. Die Deutsche Bank konnte in den letzten Tagen Boden gut... ► Artikel lesen | |
| GRAYSCALE ETHEREUM STAKING MINI | 20,090 | 0,00 % | Grayscale Ethereum Staking Mini ETF - 8-K, Current Report | ||
| COMMERZBANK | 35,640 | +0,54 % | Dax startet im Plus - Commerzbank-Aktien gefragt | Frankfurt/Main - Der Dax ist am Montag mit Zugewinnen in den Handelstag gestartet. Um 9:30 Uhr wurde der deutsche Leitindex mit rund 24.848 Punkten berechnet und damit 0,5 Prozent über dem Schlussniveau... ► Artikel lesen | |
| PAGAYA TECHNOLOGIES | 14,190 | 0,00 % | Morning Market Movers: MDJM Ltd., Kyndryl, Hims & Hers, Pagaya Technologies See Big Swings | BEIJING (dpa-AFX) - At 8:15 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BLUE OWL CAPITAL | 12,645 | 0,00 % | Blue Owl Capital Inc. Fourth Quarter 2025 Results | NEW YORK, Feb. 5, 2026 /PRNewswire/ -- Blue Owl Capital Inc. (NYSE:OWL) ("Blue Owl") today reported its financial results for the fourth quarter ended December... ► Artikel lesen | |
| BITWISE BITCOIN | 38,430 | 0,00 % | Bitwise Bitcoin ETF - 10-Q, Quarterly Report | ||
| FIDELITY WISE ORIGIN BITCOIN FUND | 61,63 | 0,00 % | Fidelity Wise Origin Bitcoin Fund - 8-K, Current Report | ||
| ROCKET COMPANIES | 19,605 | +3,84 % | Rocket Companies, Inc. (RKT): A Bull Case Theory | ||
| DIREXION DAILY S&P 500 BEAR 3X | 33,875 | 0,00 % | Direxion Daily S&P 500 Bear 3X Shares declares quarterly distribution of $0.1934 | ||
| DIREXION DAILY SEMICONDUCTOR BEAR 3X | 1,805 | 0,00 % | Direxion Daily Semiconductor Bear 3X Shares declares quarterly distribution of $0.0409 |
KDVENTURES AB gehört der Branche Finanzdienstleistungen an. Mit einer aktuellen Kursveränderung von -0,006 (-20,32 %) liegt der Kurs bei 0,025 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu KDVENTURES AB finden Sie auf Wallstreet Online.